文献速递心脏核医学

靶向SST2的[111In]In-DOTA-JR11用于动脉粥样硬化斑块炎症成像

Imaging inflammation in atherosclerotic plaques, targeting SST2 with [111In]In-DOTA-JR11.
PubMed 文献 · J Nucl Cardiol · 2020-02-05

本研究在动脉粥样硬化ApoE-/-小鼠(n=22)中评估靶向生长抑素受体亚型2(SST2)的[111In]In-DOTA-JR11用于斑块检测的潜力。注射[111In]In-DOTA-JR11后2小时SPECT/CT显示所有小鼠均可见斑块摄取,靶本比(TBR)为2.23±0.35。离体扫描及人颈动脉内膜切除标本证实放射性配体在含CD68和SST2表达细胞的斑块部位摄取,提示DOTA-JR11是有前景的动脉粥样硬化斑块炎症显像配体。

要点

  • 动脉粥样硬化ApoE-/-小鼠(n=22)注射[111In]In-DOTA-JR11后2小时SPECT/CT可见斑块摄取,TBR为2.23±0.35。
  • 胸腺切除后尸检扫描和离体动脉扫描TBR分别为2.46±0.52和3.43±1.45,油红O染色和离体放射自显影显示摄取位于斑块部位。
  • 人颈动脉内膜切除标本的SPECT/CT、体外放射自显影和免疫组化显示[111In]In-DOTA-JR11摄取位于含CD68和SST2表达细胞的斑块部位。

核心结论

  • 本研究结果表明DOTA-JR11是有前景的用于动脉粥样硬化斑块炎症可视化的配体。

研究设计与样本

  • 研究采用动脉粥样硬化ApoE-/-小鼠(n=22),喂食致动脉粥样硬化饮食,注射[111In]In-DOTA-JR11(约200 pmol,约50 MBq)后2小时行SPECT/CT显像。
  • 研究另对胸腺切除后尸检扫描、离体动脉扫描、离体放射自显影、油红O脂质染色、组织学处理及人颈动脉内膜切除标本的SPECT/CT、体外放射自显影和免疫组化进行分析。

主要发现

  • 所有小鼠体内均可见[111In]In-DOTA-JR11斑块摄取,靶本比(TBR)为2.23±0.35。
  • 胸腺切除后尸检扫描和离体动脉扫描的TBR分别为2.46±0.52和3.43±1.45。
  • 油红O脂质染色和离体放射自显影显示[111In]In-DOTA-JR11摄取位于斑块部位。
  • 组织学处理显示斑块内存在CD68(巨噬细胞)和SST2表达细胞。
  • 人颈动脉内膜切除标本切片的SPECT/CT、体外放射自显影和免疫组化显示[111In]In-DOTA-JR11摄取位于含CD68和SST2表达细胞的斑块部位。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Imaging Somatostatin Subtype Receptor 2 (SST2) expressing macrophages by [DOTA,Tyr3]-octreotate (DOTATATE) has proven successful for plaque detection. DOTA-JR11 is a SST2 targeting ligand with a five times higher tumor uptake than DOTATATE, and holds promise to improve plaque imaging. The aim of this study was to evaluate the potential of DOTA-JR11 for plaque detection. METHODS AND RESULTS: Atherosclerotic ApoE-/- mice (n = 22) fed an atherogenic diet were imaged by SPECT/CT two hours post injection of [111In]In-DOTA-JR11 (~ 200 pmol, ~ 50 MBq). In vivo plaque uptake of [111In]In-DOTA-JR11 was visible in all mice, with a target-to-background-ratio (TBR) of 2.23 ± 0.35. Post-mortem scans after thymectomy and ex vivo scans of the arteries after excision of the arteries confirmed plaque uptake of the radioligand with TBRs of 2.46 ± 0.52 and 3.43 ± 1.45 respectively. Oil red O lipid-staining and ex vivo autoradiography of excised arteries showed [111In]In-DOTA-JR11 uptake at plaque locations. Histological processing showed CD68 (macrophages) and SST2 expressing cells in plaques. SPECT/CT, in vitro autoradiography and immunohistochemistry performed on slices of a human carotid endarterectomy sample showed [111In]In-DOTA-JR11 uptake at plaque locations containing CD68 and SST2 expressing cells. CONCLUSIONS: The results of this study indicate DOTA-JR11 as a promising ligand for visualization of atherosclerotic plaque inflammation.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Meester EJ, Krenning BJ, de Blois E, et al. Imaging inflammation in atherosclerotic plaques, targeting SST2 with [111In]In-DOTA-JR11. J Nucl Cardiol. 2020. PMID: 32026330. doi:10.1007/s12350-020-02046-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。